Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target
Prostate cancer (PC) is a commonly diagnosed malignancy in men and is associated with high mortality rates. Current treatments for PC include surgery, chemotherapy, and radiation therapy. However, recent advances in targeted delivery systems have yielded promising new approaches to PC treatment. As...
Main Authors: | Amir Yarahmadi, Romoye Sohan, Brenna McAllister, Leslie A. Caromile |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2022.2136476 |
Similar Items
-
Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance
by: Demetrios N. Simopoulos, et al.
Published: (2017-09-01) -
PSMA redirects MAPK to PI3K-AKT signaling to promote prostate cancer progression
by: Leslie Ann Caromile, et al.
Published: (2017-07-01) -
PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives
by: Mohamed El Fakiri, et al.
Published: (2021-08-01) -
Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment
by: Yingying Zhang, et al.
Published: (2022-04-01) -
Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer
by: Pietro Pepe, et al.
Published: (2022-09-01)